These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21269955)

  • 1. [hTERT single nucleotide polymorphism is associated with increased risks of hepatocellular carcinoma and tumor metastasis].
    Dong J; Wang L; Tian YP; Guo Y; Liu HY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):49-52. PubMed ID: 21269955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
    Chen TY; Li YC; Liu YF; Tsai CM; Hsieh YH; Lin CW; Yang SF; Weng CJ
    Ann Surg Oncol; 2011 Aug; 18(8):2348-56. PubMed ID: 21298348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
    Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
    Dai D; Zhai W; Zhu T; Zhu H; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
    Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
    J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
    Wang XQ; Luk JM; Garcia-Barcelo M; Miao X; Leung PP; Ho DW; Cheung ST; Lam BY; Cheung CK; Wong AS; Lau SS; So MT; Yu WC; Cai Q; Liu KS; Hui CK; Lau GK; Poon RT; Wong J; Fan ST
    Clin Cancer Res; 2006 Sep; 12(17):5248-52. PubMed ID: 16951245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection].
    Huang XY; Huang ZL; Tang ZY; Xu B; Zheng Q; Zhou J; Wang L; Ye SL
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1278-82. PubMed ID: 20646604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation.
    Li XD; Wu LM; Xie HY; Xu X; Zhou L; Liang TB; Wang WL; Shen Y; Zhang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):254-8. PubMed ID: 17548247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].
    Kim YJ; Lee HS
    Korean J Hepatol; 2009 Mar; 15(1):7-14. PubMed ID: 19346781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
    Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
    Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma.
    Zhu ZZ; Di JZ; Gu WY; Cong WM; Gawron A; Wang Y; Zheng Q; Wang AZ; Zhu G; Zhang P; Hou L
    Oncology; 2010; 78(5-6):382-8. PubMed ID: 20798561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.